• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 1,2,4-三唑并[4,3-a]喹喔啉-1-酮骨架的高活性和选择性人腺苷 A₃ 受体荧光拮抗剂。

Highly potent and selective fluorescent antagonists of the human adenosine A₃ receptor based on the 1,2,4-triazolo[4,3-a]quinoxalin-1-one scaffold.

机构信息

School of Pharmacy, Centre for Biomolecular Sciences, University of Nottingham, United Kingdom.

出版信息

J Med Chem. 2012 Feb 23;55(4):1771-82. doi: 10.1021/jm201722y. Epub 2012 Feb 13.

DOI:10.1021/jm201722y
PMID:22277057
Abstract

The adenosine-A(3) receptor (A(3)AR) is a G protein-coupled receptor that shows promise as a therapeutic target for cancer, glaucoma, and various autoimmune inflammatory disorders, and as such, there is a need for molecular probes to study this receptor. Here, we report a series of fluorescent ligands containing different linkers and fluorophores based around a 1,2,4-triazolo[4,3-a]quinoxalin-1-one antagonist. One of these conjugates (19) displayed high affinity for the A(3)AR (pK(D) = 9.36 ± 0.12) and is >650-fold selective over other adenosine receptor subtypes. Confocal microscopy revealed clear, displaceable membrane labeling of CHO-A(3) cells with 19, with no detectable labeling of CHO-A(1) cells under identical conditions. This fluorescent ligand was also able to specifically label the A(3)AR in HEK293T cells containing a mixed adenosine receptor population. The subtype specificity, along with its excellent imaging properties, make 19 an ideal tool for studying A(3)AR distribution and organization, particularly in the presence of other adenosine receptor subtypes.

摘要

腺苷 A(3) 受体 (A(3)AR) 是一种 G 蛋白偶联受体,作为癌症、青光眼和各种自身免疫性炎症性疾病的治疗靶点具有很大的潜力,因此,需要有分子探针来研究这种受体。在这里,我们报告了一系列基于 1,2,4-三唑并[4,3-a]喹喔啉-1-酮拮抗剂的含有不同连接子和荧光团的荧光配体。其中一种缀合物(19)对 A(3)AR 表现出高亲和力(pK(D) = 9.36 ± 0.12),对其他腺苷受体亚型的选择性超过 650 倍。共焦显微镜显示,19 可以清晰、可置换地标记 CHO-A(3) 细胞的膜,而在相同条件下,CHO-A(1) 细胞没有可检测到的标记。这种荧光配体还能够在含有混合腺苷受体群体的 HEK293T 细胞中特异性标记 A(3)AR。19 的亚型特异性及其出色的成像特性使其成为研究 A(3)AR 分布和组织的理想工具,特别是在存在其他腺苷受体亚型的情况下。

相似文献

1
Highly potent and selective fluorescent antagonists of the human adenosine A₃ receptor based on the 1,2,4-triazolo[4,3-a]quinoxalin-1-one scaffold.基于 1,2,4-三唑并[4,3-a]喹喔啉-1-酮骨架的高活性和选择性人腺苷 A₃ 受体荧光拮抗剂。
J Med Chem. 2012 Feb 23;55(4):1771-82. doi: 10.1021/jm201722y. Epub 2012 Feb 13.
2
1,2,4-triazolo[4,3-a]quinoxalin-1-one moiety as an attractive scaffold to develop new potent and selective human A3 adenosine receptor antagonists: synthesis, pharmacological, and ligand-receptor modeling studies.1,2,4-三唑并[4,3-a]喹喔啉-1-酮部分作为开发新型强效和选择性人A3腺苷受体拮抗剂的有吸引力的骨架:合成、药理学及配体-受体模型研究
J Med Chem. 2004 Jul 1;47(14):3580-90. doi: 10.1021/jm031136l.
3
4-amido-2-aryl-1,2,4-triazolo[4,3-a]quinoxalin-1-ones as new potent and selective human A3 adenosine receptor antagonists. synthesis, pharmacological evaluation, and ligand-receptor modeling studies.新型强效选择性人A3腺苷受体拮抗剂4-氨基-2-芳基-1,2,4-三唑并[4,3-a]喹喔啉-1-酮:合成、药理学评价及配体-受体模型研究
J Med Chem. 2006 Jun 29;49(13):3916-25. doi: 10.1021/jm060373w.
4
The identification of the 2-phenylphthalazin-1(2H)-one scaffold as a new decorable core skeleton for the design of potent and selective human A3 adenosine receptor antagonists.将 2-苯基酞嗪-1(2H)-酮骨架鉴定为设计强效和选择性人 A3 腺苷受体拮抗剂的新可修饰核心骨架。
J Med Chem. 2011 Apr 14;54(7):2102-13. doi: 10.1021/jm101328n. Epub 2011 Mar 14.
5
Scouting human A3 adenosine receptor antagonist binding mode using a molecular simplification approach: from triazoloquinoxaline to a pyrimidine skeleton as a key study.采用分子简化方法探索人 A3 腺苷受体拮抗剂的结合模式:从三唑并喹喔啉到嘧啶骨架的关键研究
J Med Chem. 2007 Dec 27;50(26):6596-606. doi: 10.1021/jm070852a. Epub 2007 Nov 30.
6
New 2-heterocyclyl-imidazo[2,1-i]purin-5-one derivatives as potent and selective human A3 adenosine receptor antagonists.新型 2-杂环基-咪唑并[2,1-i]嘌呤-5-酮衍生物作为有效的和选择性的人 A3 腺苷受体拮抗剂。
J Med Chem. 2011 Jul 28;54(14):5205-20. doi: 10.1021/jm2004738. Epub 2011 Jun 28.
7
5-amino-2-phenyl[1,2,3]triazolo[1,2-a][1,2,4]benzotriazin-1-one: a versatile scaffold to obtain potent and selective A3 adenosine receptor antagonists.5-氨基-2-苯基[1,2,3]三唑并[1,2-a][1,2,4]苯并三嗪-1-酮:一种用于获得强效和选择性A3腺苷受体拮抗剂的多功能骨架。
J Med Chem. 2007 Nov 15;50(23):5676-84. doi: 10.1021/jm0708376. Epub 2007 Oct 10.
8
1,2,4-Triazolo[1,5-a]quinoxaline as a versatile tool for the design of selective human A3 adenosine receptor antagonists: synthesis, biological evaluation, and molecular modeling studies of 2-(hetero)aryl- and 2-carboxy-substituted derivatives.1,2,4-三唑并[1,5-a]喹喔啉作为设计选择性人A3腺苷受体拮抗剂的通用工具:2-(杂)芳基和2-羧基取代衍生物的合成、生物学评价及分子模拟研究
J Med Chem. 2005 Dec 15;48(25):7932-45. doi: 10.1021/jm0504149.
9
1,2,4-triazolo[1,5-a]quinoxaline derivatives and their simplified analogues as adenosine A₃ receptor antagonists. Synthesis, structure-affinity relationships and molecular modeling studies.1,2,4-三唑并[1,5-a]喹喔啉衍生物及其简化类似物作为腺苷A₃受体拮抗剂。合成、构效关系及分子模拟研究。
Bioorg Med Chem. 2015 Jan 1;23(1):9-21. doi: 10.1016/j.bmc.2014.11.033. Epub 2014 Nov 27.
10
Conversion of a non-selective adenosine receptor antagonist into A3-selective high affinity fluorescent probes using peptide-based linkers.利用基于肽的连接物将非选择性腺苷受体拮抗剂转化为 A3 选择性高亲和力荧光探针。
Org Biomol Chem. 2013 Sep 14;11(34):5673-82. doi: 10.1039/c3ob41221k.

引用本文的文献

1
A novel and selective fluorescent ligand for the study of adenosine A receptors.一种新型、选择性的荧光配体,用于研究腺苷 A 受体。
Pharmacol Res Perspect. 2024 Aug;12(4):e1223. doi: 10.1002/prp2.1223.
2
Design, Synthesis, and Evaluation of a New Chemotype Fluorescent Ligand for the P2Y Receptor.一种新型P2Y受体化学类型荧光配体的设计、合成与评价
ACS Med Chem Lett. 2024 Jun 12;15(7):1127-1135. doi: 10.1021/acsmedchemlett.4c00211. eCollection 2024 Jul 11.
3
..
J Med Chem. 2023 Aug 24;66(16):11399-11413. doi: 10.1021/acs.jmedchem.3c00854. Epub 2023 Aug 2.
4
Selective activation of Gαob by an adenosine A receptor agonist elicits analgesia without cardiorespiratory depression.腺苷 A 受体激动剂选择性激活 Gαob 可产生镇痛作用而不引起心肺抑制。
Nat Commun. 2022 Jul 18;13(1):4150. doi: 10.1038/s41467-022-31652-2.
5
Optimization of Peptide Linker-Based Fluorescent Ligands for the Histamine H Receptor.基于肽键的荧光配体对组胺 H 受体的优化。
J Med Chem. 2022 Jun 23;65(12):8258-8288. doi: 10.1021/acs.jmedchem.2c00125. Epub 2022 Jun 3.
6
Subtype selective fluorescent ligands based on ICI 118,551 to study the human β2-adrenoceptor in CRISPR/Cas9 genome-edited HEK293T cells at low expression levels.基于 ICI 118,551 的亚型选择性荧光配体,用于在低表达水平的 CRISPR/Cas9 基因编辑 HEK293T 细胞中研究人β2-肾上腺素受体。
Pharmacol Res Perspect. 2021 May;9(3):e00779. doi: 10.1002/prp2.779.
7
Pharmacological characterisation of novel adenosine A receptor antagonists.新型腺苷 A 受体拮抗剂的药理学特性。
Sci Rep. 2020 Nov 27;10(1):20781. doi: 10.1038/s41598-020-74521-y.
8
Chemical Probes for the Adenosine Receptors.腺苷受体的化学探针
Pharmaceuticals (Basel). 2019 Nov 12;12(4):168. doi: 10.3390/ph12040168.
9
NanoBRET: The Bright Future of Proximity-Based Assays.纳米生物发光共振能量转移技术:基于邻近分析的光明未来。
Front Bioeng Biotechnol. 2019 Mar 26;7:56. doi: 10.3389/fbioe.2019.00056. eCollection 2019.
10
A live cell NanoBRET binding assay allows the study of ligand-binding kinetics to the adenosine A receptor.活细胞 NanoBRET 结合测定法可用于研究配体与腺苷 A 受体的结合动力学。
Purinergic Signal. 2019 Jun;15(2):139-153. doi: 10.1007/s11302-019-09650-9. Epub 2019 Mar 27.